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OBJECTIVES: To evaluate the postoperative pathological characteristics of hysterectomy specimens, preopera-
tive cancer antigen (CA)-125 levels and imaging modalities in patients with endometrial cancer and to build a
risk matrix model to identify and recruit patients for retroperitoneal lymphadenectomy.
METHODS: A total of 405 patients undergoing surgical treatment for endometrial cancer were retrospectively
reviewed and analyzed. Clinical (age and body mass index), laboratory (CA-125), radiological (lymph node
evaluation), and pathological (tumour size, grade, lymphovascular space invasion, lymph node metastasis, and
myometrial invasion) parameters were used to test the ability to predict lymph node metastasis. Four
parameters were selected by logistic regression to create a risk matrix for nodal metastasis.
RESULTS: Of the 405 patients, 236 (58.3%) underwent complete pelvic and para-aortic lymphadenectomy, 96
(23.7%) underwent nodal sampling, and 73 (18%) had no surgical lymph node assessment. The parameters
predicting nodal involvement obtained through logistic regression were myometrial infiltration 450%,
lymphovascular space involvement, pelvic lymph node involvement by imaging, and a CA-125 value421.5 U/mL.
According to our risk matrix, the absence of these four parameters implied a risk of lymph node metastasis
of 2.7%, whereas in the presence of all four parameters the risk was 82.3%.
CONCLUSION: Patients without deep myometrial invasion and lymphovascular space involvement on the final
pathological examination and with normal CA-125 values and lymph node radiological examinations have a
relatively low risk of lymph node involvement. This risk assessment matrix may be able to refer patients with
high-risk parameters necessitating lymphadenectomy and to decide the risks and benefits of lymphadenectomy.
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’ INTRODUCTION
Lymph node (LN) metastasis is the most important
prognostic factor in endometrial cancer (1). Approximately
10% of patients diagnosed with clinically apparent early-stage
endometrial cancer will be upstaged due to LN involvement (2).
Although the role of pelvic lymphadenectomy in early-stage
disease was depicted as controversial by two prospective
randomized trials, the analysis of the available retrospective
data in high-risk patients demonstrated a survival benefit
(3,4,5). Currently, the most accurate method to assess the status
of the retroperitoneal LNs is surgical removal followed by
histopathological analysis. Indeed, this information is crucial
for correctly defining the prognosis and tailoring the use of
adjuvant oncological therapies. Although the experience of
the surgical team with the procedure reduces major intraopera-
tive risks, the risk of postoperative complications, such as
deep venous thromboses, potentially fatal pulmonary emboli,
chylous ascites formation, lymphocele formation, and lymphe-
dema, remains considerable (6).
Diverse pre- and peri-operative test modalities, such as
imaging techniques (magnetic resonance imaging (MRI) and
computed tomography (CT)), intraoperative pathological
examination of the LNs, sentinel LN biopsy, and final uterine
pathological findings, may guide additional (in the same
surgery or as a second step surgery) interventions on the LNs
(7,8). Moreover, several risk models and scoring systems can
be used to avoid unnecessary lymphadenectomies in patients
with low-risk disease (8-13).
Nodal dissection requires surgeons with oncological
expertise. However, these professionals are frequently not
available, particularly in developing countries where accessDOI: 10.6061/clinics/2017(01)06
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to advanced operative care is very limited. To illustrate, in
some parts of Latin America, approximately one-quarter of
the population lives in rural areas that are out of reach of
oncology centres (14). Therefore, the implementation of stan-
dard oncologic care is lacking due to a shortage of qualified
surgeons. In this setting, the management of apparently
early-stage Endometrial Cancer (EC) could be offered in a
two-step approach to avoid unacceptable delays in operative
therapy. The rationale behind this oncological concept is the
rapid implementation of a simple hysterectomy and bilateral
salpingo-oophorectomy (BSO) without upfront nodal dissec-
tion as the first-line treatment, followed by subsequent referral
of the patients to cancer reference centres to adequately evaluate
the necessity of a secondary lymphadenectomy (14,15).
The present study aimed to evaluate the postoperative
pathological characteristics of hysterectomy specimens, a
preoperative analysis of a tumour marker (cancer antigen
(CA)-125) and the imaging results to build a risk matrix
model for the identification and recruitment of patients for
lymphadenectomy following hysterectomy for seemingly
early-stage disease.
’ MATERIALS AND METHODS
Patients and data
The study was conducted in the Instituto do Câncer do
Estado de São Paulo do Hospital das Clínicas da Faculdade
de Medicina da Universidade de São Paulo, Brazil and was
approved by the institutional review board of the hospital
(#457.913).
Patients who underwent surgery for epithelial endometrial
carcinoma between January 2009 and March 2015 were
retrospectively analyzed. Clinical, laboratory, imaging, and
histological data were obtained from the electronic medical
records. Stromal tumours were excluded from the study.
The following clinical data were recorded: age, race, body
mass index (BMI), and the type and histological grade of the
cancer in the preoperative biopsy material. The following
histopathological parameters were recorded: histological
type, histological grade, tumour size, depth of myometrial
invasion, presence of lymphovascular space invasion (LVSI),
number of removed pelvic and para-aortic LNs, and
presence of nodal metastasis. LN involvement was rated as
pelvic, para-aortic, or pelvic and para-aortic.
During the preoperative MRI examination, the tumour size,
depth of myometrial invasion, and involvement of the pelvic
and para-aortic LNs were evaluated. LNs were considered
radiologically positive when they were larger than 1.0 cm in the
short axis and had a round morphology, MRI signals in T2
sequences similar to those of the tumour, and a restriction to
diffusion greater than or equal to the tumour. Only the size and
morphological criteria were evaluated during the CT scan.
The CA-125 level was measured at least 24 hours before
surgery.
Statistical analysis
The age, BMI, serum CA-125 level, and tumour size were
treated as numeric variables. The race, histological type,
histological grade, depth of myometrial invasion, LN
involvement by imaging, presence of LVSI, and presence
of LN metastasis were treated as categorical variables.
A p-value o0.05 was considered significant.
The association between the predictive variables and the
presence or absence of LN metastasis was assessed by
building contingency tables and subsequently evaluating the
same variables using the Boschloo test, which is a uniformly
more powerful variant of Fisher’s exact test (16). The effect
size (odds ratio) and its 95% confidence interval were also
calculated.
Given the existence of several significant associations
between the predictive variables and LN involvement, a
stepwise logistic regression was performed to identify the
variable combinations with a better predictive performance.
The appropriateness of the models was evaluated using the
Akaike information criterion (17).
’ RESULTS
Patient population
Among the 408 patients with endometrial cancer who
underwent surgery at the institution, three with a diagnosis
of carcinosarcoma were excluded from the study. Therefore,
405 patients fulfilled the inclusion criteria and were
considered eligible for the analysis. Of these 405 patients,
268 underwent laparoscopy, 132 underwent laparotomy, and
5 underwent robotic surgery. The epidemiological features of
the included patients are reported in Table 1.
Table 1 - Characteristics of the study population.
Variable N=405 (100%)
Age
Median (mean) 63 (63.6)
Range 31–91
Race
Caucasian 313 (77.3%)
Black 42 (10.4%)
Other 50 (12.3%)
BMI (kg/m2)
Median (mean) 27.8 (32.2)
Range 19.2–58
Histologic type
Endometrioid 326 (80.5%)
Serous 60 (14.8%)
Clear cell 19 (4.7%)
Grade
Low 283 (69.8%)
High 122 (30.1%)
FIGO stage
IA 178 (44.0%)
IB 81 (20%)
II 29 (7.2%)
IIIA 22 (5.4%)
IIIB 8 (2.0%)
IIIC1 37 (9.1%)
IIIC2 32 (7.9%)
IVA 2 (0.5%)
IVB 16 (4.0%)
Myometrial infiltration
o 50% 198 (48.9%)
4 50% 196 (48.4%)
Unknown 11 (2.7%)
Lymphovascular space invasion
Yes 128 (31.6%)
No 267 (65.9%)
Unknown 10 (2.5%)
Tumour size (cm)
Median 4
Range (0–13)
*BMI: Body mass index.
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Most of the analyzed patients (86.7%) were overweight or
obese (BMI425 kg/m2), including 90.2% of the patients with
type I endometrial cancer (grades 1 and 2 endometrioid
carcinoma). Of the patients with type II endometrial cancer
(grade 3 endometrioid tumours and tumours with non-
endometrioid histology), 83.2% were overweight or obese,
whereas 83.1% of the patients with LN metastasis were
overweight or obese.
CA-125
CA-125 was measured preoperatively in 334 of the 405
patients studied (82.5%). The mean CA-125 value was
21.9 U/mL (range: 4.8–1,577). A receiver operating charac-
teristics (ROC) curve was constructed for the 236 cases in
which a systematic lymphadenectomy (pelvic and para-
aortic) was performed to determine the best cut-off value to
predict LN involvement. The most appropriate cut-off value
was 21.5 U/mL, which resulted in 80.3% sensitivity, 60%
specificity and 72.9% accuracy (area under the curve (AUC)
po0.001) (Figure 1).
Histological variables
The histological parameters are presented in Table 1. The
majority of the patients had low-grade endometrioid histol-
ogy. More than half of the patients studied had tumours
confined to the uterus. LVSI was present in almost one-third of
the studied group. The median tumour size was 4 cm.
Imaging characteristics
Pelvic and abdominal MRI and/or CT images were
analyzed to predict pelvic and para-aortic LN metastasis.
In total, 385 patients (95.1%) had pelvic images and 377
(93.1%) had para-aortic images available for the analysis.
Lymph nodes
Of the 405 patients studied, 332 (82%) had at least one LN
dissected. The evaluation was complete (pelvic and para-
aortic) in 236 (58.3%) patients. Lymphadenectomy could not
be performed in 73 (18%) patients due to technical
difficulties, poor patient clinical conditions, or complications
during surgery. The mean numbers of pelvic and para-aortic
LNs were 13 (±10.9) and 6.5 (±8.1), respectively.
Of the 236 patients who underwent complete lymphade-
nectomy, 74.8% had no LN involvement. Isolated para-aortic
LN metastasis was observed in 5 (2.1%) cases. None of the
parameters alone or in conjunction were associated with the
presence of isolated para-aortic involvement (data not shown).
Myometrial infiltration, lymphovascular invasion, invol-
vement of pelvic LN detected by MRI or CT, and CA-125
levels with a cut-off of 21.5 U/mL were examined by
stepwise logistic regression to find combinations of variables
better able to predict LN metastasis. These values are shown
in Table 2.
A matrix of the probability of LN involvement was created
based on the variables selected by logistic regression. Avalue
of (1) was assigned for the presence and (0) for the absence of
the variables (Table 3). The risk of LN metastasis ranged from
2.7% in patients with myometrial infiltrationo50%, no LVSI,
image negative LNs, and a CA-125 level o21.5 U/mL to
82.3% when all four parameters were positive.
Lymphadenectomy procedure complications
The most relevant complications associated with lympha-
denectomywere vascular, neurological, urological and lymphocele
complications. Of the patients undergoing lymphadenect-
omy, 41 (12.3%) had some type of the complications listed
above. The patients who did not undergo lymphadenectomy
had fewer complications (4, 5.5%), but the difference was not
significant.
’ DISCUSSION
Retroperitoneal lymphadenectomy is among the most
controversial and questionable surgical procedures for the
treatment of EC. Nevertheless, this procedure remains an
integral part of the surgical therapy for EC according to the
latest International Federation of Gynecology and Obstetrics
(FIGO) staging system. Certainly, the oncological benefit
must be balanced against morbidity, and this equation is
difficult to elucidate. Over the last decade, diverse strategies
to select patients in whom nodal dissection may be omitted
have been proposed and investigated, but none of these
strategies have been universally accepted without criticism.
Ideally, a risk evaluation model should be designed to correctly
predict the chances of LN metastasis during the preoperative
treatment phase. Following this rational, patients at low risk
for lymphatic tumour spread could be more adequately
identified, properly informed, and better counselled to reduce
the hazards of potentially needless interventions.
In this study, the factors associated with LN involvement
in early-stage endometrial cancer were evaluated, and the
probability of LN metastasis was assessed using a predictive
model. In contrast, with previous studies and other risk
matrices, our model incorporates crucial information obtai-
ned from the initial hysterectomy. We have worked exten-
sively to create a model of risk assessment by stratifying
patients after upfront hysterectomy and salpingo-oophorect-
omy who did not undergo surgical nodal assessment into risk
groups to determine the necessity of a second surgery for
retroperitoneal lymphadenectomy. Certainly, definitive pathol-
ogy of uterine specimen provides unique and reliable data
regarding local tumour staging and histological grading
compared with preoperative endometrial biopsy and diverse
imaging modalities. This information is essential for the
Figure 1 - ROC curve for CA-125 in lymph node metastasis
prediction. Se: sensitivity, Sp: specificity, AUC: area under the curve.
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construction of more accurate risk matrices for nodal
metastasis.
A significant number of patients diagnosed with endome-
trial cancer live in underserved regions of the world. These
women have limited access to adequate on-site oncological
surgical care, including a lack of professionals trained to
perform retroperitoneal nodal dissection. This situation
could lead to an extensive delay in initiating treatment,
thereby potentially reducing patient survival. In this popula-
tion, a primary hysterectomy with BSO regardless of the
operative route followed by an evaluation of the pathological
uterine parameters may stratify patients more adequately to
identify those at high risk for lymphatic spread. These
patients should receive a secondary lymphadenectomy in a
tertiary oncological referral centre (16,17). After the pre-
operative imaging study (the status of LNs in pelvic MRI
or CT), the uterine pathological findings (deep myometrial
invasion o or 4 50%), LVSI, and a CA-125 value above
21 U/mL were shown to be associated with nodal metastasis
in the logistic regression analysis. Using these parameters,
we built an innovative risk assessment matrix to more
correctly predict the odds for nodal involvement.
A number of helpful algorithms have been proposed to
evaluate the status of LNs (8-13) and to select patients who
should receive a retroperitoneal nodal dissection. The most
widely used algorithm was proposed by Mariani et al., 2008
(18). According to this algorithm, patients with grade 1 or 2
endometrioid carcinoma with superficial (less than half of
the uterine thickness) myometrial invasion and a maximal
tumour dimension of 2 cm (analyzed by intraoperative
frozen section) could be spared from retroperitoneal lym-
phadenectomy based on their negligible rate of nodal
metastasis. When these criteria are applied to women in
industrialized nations, approximately one-third can be safely
spared nodal dissection (18). However, the application of
these criteria to women in developing countries would spare
only 8.4% of the patients from undergoing lymphadenect-
omy. One explanation for this epidemiological phenomenon
is that the endometrial cancer diagnosis and therapy more
frequently occur in a later phase of the disease in developing
countries. Consequently, the vast majority of the available
risk assessment algorithms in the literature are of very
limited use in developing nations, and a more realistic and
adequate model for these populations is certainly needed.
Indeed, this issue is one of the strongest points of the present
study, in which we tested the utility of several known risk
parameters in a different cohort of patients.
Lee et al. proposed a model that incorporated preoperative
parameters, including the histological tumour grade, pre-
operative CA-125 level, local disease extension, and myo-
metrial invasion, to detect patients at low risk for nodal
metastasis (12). In this model, the uterine tumour evaluation
(lesion size and myometrial and/or cervical infiltration) was
assessed by preoperative MRI. The authors also proposed
two different cut-off values for CA-125 (28 U/mL for patients
aged450 years and 70 U/mL for patients aged p50 years).
Use of this model in South Korean women showed that
approximately half of the included patients were classified as
low-risk, and LN metastasis was not observed in any of the
patients after systematic lymphadenectomy. The study
concluded that a preoperative prediction system to identify
the risk of LN metastasis was feasible and thus models of
risk assessment might be useful in preoperative counselling
about the costs and benefits of systemic LN dissection.
However, this study enrolled a relatively small number of
women (110) and was performed in a developed country. In
Table 2 - Logistic regression.
Lymph node metastasis risk
OR
CI 95%
Myometrial infiltration 2.12 0.86-5.79
Lymphovascular space invasion 2.98 1.29-7.41
Pelvic lymph node involvement by imaging (MRI/CT) 6.49 2.86-16.9
CA125 X 21.5 U/mL 4.01 1.67-11.69
*CI: Confidence interval.
Table 3 - Risk matrix: probability of lymph node involvement based on the presence or absence of predictive variables.
Myometrial
infiltration X 50%
Lymphovascular
space invasion
Pelvic lymph node
involvement by imaging
CA125 X 21.5U/mL Probability of lymph
node involvement
0 0 0 0 2.7%
1 0 0 0 5.8%
0 1 0 0 7.8%
0 0 0 1 10.1%
1 1 0 0 15.1%
0 0 1 0 15.5%
1 0 0 1 19.3%
0 1 0 1 25.2%
1 0 1 0 27.9%
0 1 1 0 35.3%
1 1 0 1 41.6%
0 0 1 1 42.3%
1 1 1 0 53.6%
1 0 1 1 60.8%
0 1 1 1 68.6%
1 1 1 1 82.3%
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contrast to the study conducted by Lee et al., the tumour size
was not directly associated with LN metastasis in our
multivariate analysis.
Bendifallah et al. developed an algorithm with the
following parameters: age, race, tumour grade, histological
subtype, and uterine tumour evaluation, including myome-
trial invasion and cervical stromal invasion (10). The
combined analysis of these five parameters had a very good
ability to predict nodal metastasis. This risk assessment
model incorporated information from the final uterine
histopathologic examination and consequently required
surgical treatment in two steps (an initial hysterectomy
followed by a possible secondary lymphadenectomy if
indicated). This nomogram may be an interesting alternative,
particularly for patients at elevated operative risk or with
adverse technical surgical conditions. In this scenario, a more
accurate model of risk assessment obtained through a
primary hysterectomy could provide patients and profes-
sionals with a more precise estimation of the probability of
LN involvement that might be compared with the risk of a
second surgery for nodal dissection. The incorporation of
post-hysterectomy histopathological parameters could be a
major disadvantage, mainly by increasing morbidity due to
the necessity for a reoperation. Nevertheless, we must
highlight that up to 25% of the endometrioid tumours
preoperatively classified as grade 1 and more than 20%
of the carcinomas diagnosed by frozen section as grade 1-2
tumours are upgraded in the final pathological examina-
tion (19). Additionally, MRI has a considerable false negative
rate for predicting deep myometrial infiltration (up to 13%);
its accuracy depends on the equipment quality and pro-
fessional skill, and the use of this technique increases the
cost (9,20). Certainly, this lack of correspondence between
the clinical, radiological, and pathological preoperative and
postoperative findings leads to an inaccurate risk prediction
model.
Pollom et al. evaluated the pathological records and
preoperative parameters of 296 EC patients undergoing at
least a selective lymphadenectomy (8). In the multivariate
analysis, LVSI, deep myometrial involvement, and cervical
stromal invasion were significantly associated with LN
metastasis. Moreover, the tumour size (44 cm) was margin-
ally significant. Using these factors, a nomogram was
developed in which the absence of all four risk factors
implied an irrelevant risk of LN metastasis (o1%). Interest-
ingly, LVSI was strongly associated with nodal involvement,
and the authors suggested a preoperative evaluation of this
parameter in all cases. However, from a pathological
perspective, diagnosing LVSI using limited tumour samples
is extremely difficult. Only a full review of the tumour after
hysterectomy can provide the precise LVSI status.
The most important limitations of our study are its
retrospective nature and the use of data from a single
institution. Certainly, the model of risk assessment proposed
here requires external validation. Indeed, the matrix gener-
ated by our group is grounded in information obtained
through an initial hysterectomy and the evaluation of risks
concerning a potential second surgery for retroperitoneal
lymphadenectomy. In our opinion, the uterine parameters
included in our algorithm are more reliable than the
information proved by frozen sections. This approach
minimizes potential errors and enhances the precision of a
risk matrix of LN metastasis in endometrial cancer. The utili-
zation of imaging modalities for uterine staging (especially
MRI) requires experienced radiologists for an accurate
diagnosis. The interobserver and intraobserver variability
was of great importance but could not be assessed in this
study.
One strength of the present study is the large number of
included patients submitted to systematic retroperitoneal
lymphadenectomy. To the best of our knowledge, this study
is the first model of risk assessment for endometrial cancer
developed and tested in a population from a developing
country. Certain social, economic and heath care conditions
differ in these areas of the world, and these differences have
a substantial oncological impact. The tests and parameters
used to construct this risk matrix are commonly available in
underserved regions. Moreover, the operative management
of the disease in two steps addresses a crucial issue in these
nations: the provision of advanced oncological surgical care.
This approach offers reliable information for more accurate
risk assessment and better selection of patients for nodal
dissection. In areas where resources are limited, the
implementation of a two-step surgical approach and the
use of this matrix will prevent delays in the treatment of
endometrial cancer.
In conclusion, patients without deep myometrial invasion
and LVSI on the final uterine pathological examination, low
Ca-125 values (o21 U/mL) and normal radiological images
of the LNs have an extremely low risk of LN metastasis
(2.7%) that does not justify the performance of a second
surgery for nodal dissection. By utilizing this model of risk
assessment, we can more precisely stratify patients at high
risk that certainly need retroperitoneal lymphadenectomy.
This approach provides crucial and accurate information to
enable medical professionals to better counsel patients
regarding the necessity for lymphadenectomy, thereby more
adequately balancing the risks and benefits, especially in
women at elevated surgical risk. Prospective studies utilizing
the surgical treatment of type I endometrial cancer in two
steps and the external validation of this proposed risk matrix
are necessary to verify the results obtained here.
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